Effects of bisphenol A exposure on the proliferation and senescence of normal human mammary epithelial cells

Cancer Biology and Therapy

Volumn 13, Issue 5, 2012, Pages 296-306

  Qin, Xian Yang ^a,b   Fukuda, Tomokazu ^c   Yang, Linqing ^a,d   Zaha, Hiroko ^a   Akanuma, Hiromi ^a   Zeng, Qin ^a   Yoshinaga, Jun ^b   Sone, Hideko ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Bisphenol A; Breast cancer; Cell growth; Cyclin E; HMEC; Methylation; p16

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BRCA1 PROTEIN; CYCLIN E; HETEROCHROMATIN PROTEIN 1; HETEROCHROMATIN PROTEIN 1 GAMMA; PROTEIN P16; PROTEIN TNFRSF10D; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

EID: 84863229519     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.18942     Document Type: Article

References (59)

1. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24:139-77; PMID:17825522; http://dx.doi.org/10.1016/j.reprotox.2007.07.010.
2. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 1995; 103:608-12; PMID:7556016; http://dx.doi.org/10.1289/ehp.95103608.
3. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113:391-5; PMID:15811827; http://dx.doi.org/10.1289/ ehp.7534.
4. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993; 132:2279-86; PMID:8504731; http://dx.doi.org/10.1210/en.132. 6.2279.
5. Keri RA, Ho SM, Hunt PA, Knudsen KE, Soto AM, Prins GS. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol 2007; 24:240-52; PMID:17706921; http://dx.doi. org/10.1016/j.reprotox.2007.06.008.
6. Markey CM, Luque EH, Munoz De Toro M, Sonnenschein C, Soto AM. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001; 65:1215-23; PMID:11566746.
7. Weber Lozada K, Keri RA. Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer. Biol Reprod 2011; 85:490-7; PMID:21636739; http://dx.doi.org/10.1095/biolreprod.110.090431.
8. Lamartiniere CA, Jenkins S, Betancourt AM, Wang J, Russo J. Exposure to the endocrine disruptor bisphenol a alters susceptibility for mammary cancer. Horm Mol Biol Clin Investig 2011; 5:45-52; PMID:21687816; http://dx.doi.org/10. 1515/HMBCI.2010.075.
9. Ptak A, Wrobel A, Gregoraszczuk EL. Effect of bisphenol-A on the expression of selected genes involved in cell cycle and apoptosis in the OVCAR-3 cell line. Toxicol Lett 2011; 202:30-5; PMID:21277958; http://dx.doi.org/10. 1016/j.toxlet.2011.01.015.
10. Dairkee SH, Seok J, Champion S, Sayeed A, Mindrinos M, Xiao W, et al. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res 2008; 68:2076-80; PMID:18381411; http://dx.doi.org/10.1158/0008-5472.CAN-07-6526.
11. Singleton DW, Feng Y, Yang J, Puga A, Lee AV, Khan SA. Gene expression profiling reveals novel regulation by bisphenol-A in estrogen receptor-alphapositive human cells. Environ Res 2006; 100:86-92; PMID:16029874; http://dx.doi.org/10.1016/j. envres.2005.05.004.
12. Diel P, Olff S, Schmidt S, Michna H. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J Steroid Biochem Mol Biol 2002; 80:61-70; PMID:11867264; http://dx.doi. org/10.1016/S0960-0760(01) 00173-X.
13. Weng YI, Hsu PY, Liyanarachchi S, Liu J, Deatherage DE, Huang YW, et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol 2010; 248:111-21; PMID:20678512; http://dx.doi.org/10.1016/j. taap.2010.07.014.
14. Serrano M, Blasco MA. Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol 2007; 8:715-22; PMID:17717516; http://dx.doi. org/10.1038/nrm2242.
15. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130:223-33; PMID:17662938; http://dx.doi.org/10.1016/j. cell.2007.07.003.
16. Iso T, Futami K, Iwamoto T, Furuichi Y. Modulation of the expression of bloom helicase by estrogenic agents. Biol Pharm Bull 2007; 30:266-71; PMID:17268063; http://dx.doi.org/10.1248/bpb.30.266.
17. Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 2009; 117:1053-8; PMID:19654912.
18. Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J, Russo J. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol 2008; 196:101-12; PMID:18180321; http://dx.doi. org/10.1677/JOE-07-0056.
19. de Waard WJ, Aarts JM, Peijnenburg AA, Baykus H, Talsma E, Punt A, et al. Gene expression profiling in Caco-2 human colon cells exposed to TCDD, benzo[a] pyrene and natural Ah receptor agonists from cruciferous vegetables and citrus fruits. Toxicol In Vitro 2008; 22:396-410; PMID:18061397; http://dx.doi. org/10.1016/j.tiv.2007.10.007.
20. Buterin T, Koch C, Naegeli H. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 2006; 27:1567-78; PMID:16474171; http://dx.doi.org/10.1093/ carcin/bgi339.
21. Garbe JC, Holst CR, Bassett E, Tlsty T, Stampfer MR. Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis. Cell Cycle 2007; 6:1927-36; PMID:17671422; http://dx.doi.org/10.4161/cc.6.15.4519.
22. Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci USA 1985; 82:2394-8; PMID:3857588; http://dx.doi.org/10.1073/pnas.82.8.2394.
23. Sudo H, Garbe J, Stampfer MR, Barcellos-Hoff MH, Kronenberg A. Karyotypic instability and centrosome aberrations in the progeny of finite life-span human mammary epithelial cells exposed to sparsely or densely ionizing radiation. Radiat Res 2008; 170:23-32; PMID:18582160; http://dx.doi.org/10.1667/RR1317.1.
24. Qin XY, Zaha H, Nagano R, Yoshinaga J, Yonemoto J, Sone H. Xenoestrogens downregulate aryl-hydrocarbon receptor nuclear translocator 2 mRNA expression in human breast cancer cells via an estrogen receptor alpha-dependent mechanism. Toxicol Lett 2011; 206:152-7; PMID:21771643; http://dx.doi. org/10.1016/j. toxlet.2011.07.007.
25. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007; 24:178-98; PMID:17628395; http://dx.doi. org/10.1016/j.reprotox.2007.05. 010.
26. Nijjar T, Bassett E, Garbe J, Takenaka Y, Stampfer MR, Gilley D, et al. Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells. Oncogene 2005; 24:3369-76; PMID:15735711; http://dx.doi.org/10.1038/sj.onc.1208482.
27. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007; 1:84-96; PMID:18516279; http://dx.doi. org/10.1016/j.molonc.2007.02.004.
28. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28; PMID:12042769.
29. Fleming JM, Miller TC, Meyer MJ, Ginsburg E, Vonderhaar BK. Local regulation of human breast xenograft models. J Cell Physiol 2010; 224:795-806; PMID:20578247; http://dx.doi.org/10.1002/jcp.22190.
30. Bruder ED, Lee JJ, Widmaier EP, Raff H. Microarray and real-time PCR analysis of adrenal gland gene expression in the 7-day-old rat: effects of hypoxia from birth. Physiol Genomics 2007; 29:193-200; PMID:17213367; http://dx.doi.org/10.1152/physiolgenomics. 00245.2006.
31. Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 2001; 357:1335-6; PMID:11343741; http://dx.doi.org/10.1016/S0140-6736(00)04501-3.
32. Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, et al. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 2003; 107:970-5; PMID:14601057; http://dx.doi. org/10.1002/ijc.11508.
33. Lee JS, Fackler MJ, Teo WW, Lee JH, Choi C, Park MH, et al. Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis. Cancer Biol Ther 2008; 7:1398-406; PMID:18769130; http://dx.doi.org/10.4161/cbt.7.9.6425.
34. Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001; 409:633-7; PMID:11214324; http://dx.doi. org/10.1038/35054579.
35. Sarkar P, Shiizaki K, Yonemoto J, Sone H. Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc. Int J Oncol 2006; 28:43-51; PMID:16327978.
36. Bandyopadhyay D, Curry JL, Lin Q, Richards HW, Chen D, Hornsby PJ, et al. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 2007; 6:577-91; PMID:17578512; http://dx.doi.org/10.1111/j.1474-9726.2007.00308.x.
37. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-16; PMID:12809602; http://dx.doi.org/10. 1016/S0092-8674(03)00401-X.
38. Malyavantham KS, Bhattacharya S, Barbeitos M, Mukherjee L, Xu J, Fackelmayer FO, et al. Identifying functional neighborhoods within the cell nucleus: proximity analysis of early S-phase replicating chromatin domains to sites of transcription, RNA polymerase II, HP1gamma, matrin 3 and SAF-A. J Cell Biochem 2008; 105:391-403; PMID:18618731; http://dx.doi. org/10.1002/jcb.21834.
39. Hayakawa T, Haraguchi T, Masumoto H, Hiraoka Y. Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase. J Cell Sci 2003; 116:3327-38; PMID:12840071; http://dx.doi.org/10.1242/jcs.00635.
40. Minc E, Allory Y, Worman HJ, Courvalin JC, Buendia B. Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells. Chromosoma 1999; 108:220-34; PMID:10460410; http://dx.doi. org/10.1007/ s004120050372.
41. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36:131-49; PMID:12814430; http://dx.doi.org/10.1046/j.1365-2184.2003.00266.x.
42. Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-7; PMID:8939849; http://dx.doi.org/10.1126/science. 274.5293.1672.
43. Roussel-Gervais A, Bilodeau S, Vallette S, Berthelet F, Lacroix A, Figarella-Branger D, et al. Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis. Mol Endocrinol 2010; 24:1835- 45; PMID:20660298; http://dx.doi.org/10.1210/ me.2010-0091.
44. Minella AC, Clurman BE. Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 2005; 4:1356-9; PMID:16131838; http://dx.doi.org/10.4161/cc.4.10. 2058.
45. Kitagawa K, Kotake Y, Kitagawa M. Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci 2009; 100:1374-81; PMID:19459846; http://dx.doi.org/10.1111/j.1349-7006.2009.01196.x.
46. Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 2007; 26:131-43; PMID:17434132; http://dx.doi.org/10.1016/j.molcel. 2007.02.022.
47. Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCF(Fbw7) ubiquitin ligase. Science 2001; 294:173-7; PMID:11533444; http://dx.doi.org/10.1126/ science.1065203.
48. Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bernstein ID, et al. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 2008; 22:1677- 89; PMID:18559482; http://dx.doi.org/10.1101/ gad.1650208.
49. Jenkins S, Wang J, Eltoum I, Desmond R, Lamartiniere CA. Chronic oral exposure to bisphenol a results in a non-monotonic dose response in mammary carcinogenesis and metastasis in mmtv-erbb2 mice. Environ Health Perspect 2011; 119:1604-9; PMID:21988766; http://dx.doi.org/10.1289/ehp.1103850.
50. Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M, et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009; 460:1136-9; PMID:19668188; http://dx.doi.org/10.1038/nature08290.
51. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38:1378-85; PMID:17072317; http://dx.doi. org/10.1038/ng1909.
52. Radpour R, Kohler C, Haghighi MM, Fan AX, Holzgreve W, Zhong XY. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array. Oncogene 2009; 28:2969-78; PMID:19503099; http://dx.doi.org/10.1038/onc.2009.149.
53. Dejeux E, Ronneberg JA, Solvang H, Bukholm I, Geisler S, Aas T, et al. DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. Mol Cancer 2010; 9:68; PMID:20338046; http://dx.doi.org/10.1186/1476-4598-9-68.
54. Pal R, Srivastava N, Chopra R, Gochhait S, Gupta P, Prakash N, et al. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. Mol Cancer 2010; 9:303; PMID:21092294; http://dx.doi. org/10.1186/1476-4598-9-303.
55. Moelans CB, Verschuur-Maes AH, van Diest PJ. Frequent promoter hypermethylation of BRCA2, BRCA1, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. J Pathol 2011; 225:222-31; PMID:21710692; http://dx.doi. org/10.1002/path.2930.
56. Shim YH, Kang GH, Ro JY. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 2000; 80:689-95; PMID:10830779; http://dx.doi.org/10.1038/labinvest. 3780072.
57. INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer 2010; 10:138; PMID:20388212; http://dx.doi. org/10.1186/1471-2407-10-138.
58. Zang JJ, Xie F, Xu JF, Qin YY, Shen RX, Yang JM, et al. P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis. World J Gastroenterol 2011; 17:3043-8; PMID:21799651; http://dx.doi.org/10.3748/wjg.v17.i25.3043.
59. Salvesen HB, Das S, Akslen LA. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Clin Cancer Res 2000; 6:153-9; PMID:10656444.